FDA inspection
Lonza Biologics Tuas Pte Ltd: FDA inspection ending May 19, 2023
FDA inspection 1255011 · No Action Indicated (NAI) · Singapore
Key facts
| Inspection ID | 1255011 |
|---|---|
| Firm | Lonza Biologics Tuas Pte Ltd |
| FEI number | 3009725845 |
| Address | 35 Tuas South Avenue 6 |
| City | Singapore |
| Fiscal year | 2023 |
| Inspection end date | May 19, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data